KR102565407B1 - 극성 비양자성 용매를 이용한 n-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법 - Google Patents

극성 비양자성 용매를 이용한 n-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법 Download PDF

Info

Publication number
KR102565407B1
KR102565407B1 KR1020160000212A KR20160000212A KR102565407B1 KR 102565407 B1 KR102565407 B1 KR 102565407B1 KR 1020160000212 A KR1020160000212 A KR 1020160000212A KR 20160000212 A KR20160000212 A KR 20160000212A KR 102565407 B1 KR102565407 B1 KR 102565407B1
Authority
KR
South Korea
Prior art keywords
group
compound
formula
mixture
chiral auxiliary
Prior art date
Application number
KR1020160000212A
Other languages
English (en)
Korean (ko)
Other versions
KR20170081315A (ko
Inventor
우병영
이기화
노종화
박제홍
박미영
박영호
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to KR1020160000212A priority Critical patent/KR102565407B1/ko
Priority to TW105143494A priority patent/TWI725098B/zh
Priority to JP2018534974A priority patent/JP6911033B2/ja
Priority to CN201680077743.6A priority patent/CN108473418A/zh
Priority to PCT/KR2016/015402 priority patent/WO2017119666A1/ko
Publication of KR20170081315A publication Critical patent/KR20170081315A/ko
Application granted granted Critical
Publication of KR102565407B1 publication Critical patent/KR102565407B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
KR1020160000212A 2016-01-04 2016-01-04 극성 비양자성 용매를 이용한 n-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법 KR102565407B1 (ko)

Priority Applications (5)

Application Number Priority Date Filing Date Title
KR1020160000212A KR102565407B1 (ko) 2016-01-04 2016-01-04 극성 비양자성 용매를 이용한 n-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법
TW105143494A TWI725098B (zh) 2016-01-04 2016-12-28 藉由使用極性非質子性溶劑掌性解析n-[4-(1-胺基乙基)-苯基]-磺醯胺衍生物之方法
JP2018534974A JP6911033B2 (ja) 2016-01-04 2016-12-28 極性非プロトン性溶媒を用いたn−[4−(1−アミノエチル)−フェニル]−スルホンアミド誘導体のキラル分割方法
CN201680077743.6A CN108473418A (zh) 2016-01-04 2016-12-28 使用极性非质子溶剂的n-[4-(1-氨基乙基)苯基]磺酰胺衍生物的手性拆分方法
PCT/KR2016/015402 WO2017119666A1 (ko) 2016-01-04 2016-12-28 극성 비양자성 용매를 이용한 n-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160000212A KR102565407B1 (ko) 2016-01-04 2016-01-04 극성 비양자성 용매를 이용한 n-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법

Publications (2)

Publication Number Publication Date
KR20170081315A KR20170081315A (ko) 2017-07-12
KR102565407B1 true KR102565407B1 (ko) 2023-08-10

Family

ID=59274353

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160000212A KR102565407B1 (ko) 2016-01-04 2016-01-04 극성 비양자성 용매를 이용한 n-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법

Country Status (5)

Country Link
JP (1) JP6911033B2 (zh)
KR (1) KR102565407B1 (zh)
CN (1) CN108473418A (zh)
TW (1) TWI725098B (zh)
WO (1) WO2017119666A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102587297B1 (ko) * 2017-08-31 2023-10-12 (주)아모레퍼시픽 수면장애 예방 또는 치료용 조성물
KR102518632B1 (ko) * 2018-04-18 2023-04-06 (주)아모레퍼시픽 (r)-n-[1-(3,5-다이플루오로-4-메테인설폰일아미노-페닐)-에틸]-3-(2-프로필-6-트라이플루오로메틸-피리딘-3-일)-아크릴아마이드를 함유하는 약학 조성물
CN109608368B (zh) * 2018-10-24 2021-03-09 常州市阳光药业有限公司 N-[4-(1-氨基乙基)-2,6-二氟苯基]甲磺酰胺的合成及拆分方法
CN111925380A (zh) * 2019-05-13 2020-11-13 北京化工大学 引起手性选择性转变的组合共晶客体拆分剂及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070185346A1 (en) 2006-02-03 2007-08-09 Vaidya Niteen A Kit for automated resolving agent selection and method thereof
WO2007129188A1 (en) 2006-05-10 2007-11-15 Pfizer Japan Inc. Cyclopropanecarboxamide compound

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968837A (en) * 1989-07-28 1990-11-06 Ethyl Corporation Resolution of racemic mixtures
NL1004346C2 (nl) * 1996-10-23 1998-04-24 Dsm Nv Werkwijze voor het scheiden van een mengsel van enantiomeren in een geschikt oplosmiddel.
DE19956786A1 (de) * 1999-11-25 2001-05-31 Basf Ag Verfahren zur Herstellung optisch aktiver Amine
US7301023B2 (en) * 2001-05-31 2007-11-27 Pfizer Inc. Chiral salt resolution
JP2003226677A (ja) * 2002-02-01 2003-08-12 Sumitomo Pharmaceut Co Ltd 光学活性2−(1−アミノアルキル)アニリン類およびその光学活性な酒石酸類との塩、並びにそれらの製造方法
WO2007133637A2 (en) 2006-05-10 2007-11-22 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
CA2658925C (en) * 2006-07-27 2015-07-14 Amorepacific Corporation Novel sulfonylamino acrylamide derivatives, isomer thereof,or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
EP1882687A1 (en) * 2006-07-27 2008-01-30 Amorepacific Corporation Heterocyclic compounds useful as vanilloid receptor antagonists and pharmaceutical compositions containing the same
JP2011201778A (ja) 2008-07-23 2011-10-13 Mochida Pharmaceut Co Ltd p−置換アリールアセトアミドを有するヘテロシクリデン誘導体
CN101870660A (zh) * 2010-05-10 2010-10-27 青海省青海湖药业有限公司 一种L-(-)-盐酸麻黄碱和d-(+)-盐酸伪麻黄碱制备方法
CN104119240A (zh) * 2013-04-23 2014-10-29 中国人民解放军军事医学科学院毒物药物研究所 (S)-(-)-α-甲胺基苯丙酮的制备方法
KR101791119B1 (ko) * 2015-02-17 2017-11-20 (주)아모레퍼시픽 N-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법
KR20160101554A (ko) * 2015-02-17 2016-08-25 (주)아모레퍼시픽 N-[4-(1-아미노에틸)-페닐]-메탄술폰아미드 유도체의 카이랄 분할 방법

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070185346A1 (en) 2006-02-03 2007-08-09 Vaidya Niteen A Kit for automated resolving agent selection and method thereof
WO2007129188A1 (en) 2006-05-10 2007-11-15 Pfizer Japan Inc. Cyclopropanecarboxamide compound

Also Published As

Publication number Publication date
JP6911033B2 (ja) 2021-07-28
TW201726585A (zh) 2017-08-01
WO2017119666A1 (ko) 2017-07-13
JP2019501923A (ja) 2019-01-24
KR20170081315A (ko) 2017-07-12
TWI725098B (zh) 2021-04-21
CN108473418A (zh) 2018-08-31

Similar Documents

Publication Publication Date Title
KR101791119B1 (ko) N-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법
KR20160101554A (ko) N-[4-(1-아미노에틸)-페닐]-메탄술폰아미드 유도체의 카이랄 분할 방법
KR102565407B1 (ko) 극성 비양자성 용매를 이용한 n-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법
US20080096939A1 (en) Process For Preparation Of Pramipexole By Chiral Chromatography
CN112645869B (zh) 一种马来酸氯苯那敏中间体的制备方法
JP2009520000A (ja) カンナビノイドcb1受容体モジュレーターとしての4,5−ジヒドロ−(1h)−ピラゾール誘導体
WO2016038422A1 (en) Process for the preparation of optically enriched adrenaline
KR102587339B1 (ko) N-[4-(1-아미노-에틸)-2,6-다이플루오로-페닐]-메테인설폰아마이드의 거울상 이성질체들의 라세미화 방법
KR102599958B1 (ko) (r)-n-[4-(1-아미노-에틸)-2,6-다이플루오로-페닐]-메테인설폰아마이드의 제조방법
EP3774745B1 (en) Oxazole compound crystal
EP2348013A1 (en) Process for preparation of intermediates of arformoterol
JP6000248B2 (ja) 2,3−ジアミノプロピオン酸誘導体のエナンチオマ体の製造方法
CN113429328A (zh) 手性3,3-二氟-4-氨基吡咯烷衍生物及其制备方法
KR20100029570A (ko) 비스(1-[(4-클로로페닐)페닐메틸]피페라진)-2,3-디벤조일 타르타르산 신규 중간체 염 및 이를 이용한 광학 활성적으로 순수한 1-[(4-클로로페닐)페닐메틸]피페라진을 분리하는 분리방법
EP2396334A1 (fr) Derives de n-[(2-aza-bicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique
EP2396335A1 (fr) Derives de n-[(6-aza-bicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right